Walsh & Associates’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Walsh & Associates's RMD Position: Q3 2026 in Review
Walsh & Associates held its ResMed (RMD) position steady in Q3 2026 at 120 shares worth $26.5K. The position accounts for 0.02% of the portfolio, ranked #154.
Walsh & Associates first reported a position in RMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $28.9K in Q4 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Walsh & Associates held 120 shares of ResMed worth $26.5K as of Q3 2026.
- Walsh & Associates left its ResMed share count unchanged in Q3 2026.
- ResMed made up 0.02% of Walsh & Associates's portfolio in Q3 2026, its #154 holding.
- Walsh & Associates first reported a position in ResMed in Q4 2025 and has held it in 4 quarters since.
- Walsh & Associates's ResMed position peaked at $28.9K in Q4 2025.
- 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.